Literature DB >> 11291930

Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings.

T Okusaka1, S Okada, H Ueno, M Ikeda, K Shimada, J Yamamoto, T Kosuge, S Yamasaki, N Fukushima, M Sakamoto.   

Abstract

Abdominal and/or back pain is one of the most common symptoms in patients with pancreatic cancer. However, the cause of the pain and the clinicopathologic features of patients with pain have not been fully elucidated. We retrospectively determined the factors related to preoperative abdominal and/or back pain in 95 patients with resectable pancreatic cancer. Pancreatic tumor size, invasion of the intrapancreatic nerves, invasion of the anterior pancreatic capsule, and lymph node metastasis were determined to be variables related to the pain. Pancreatic tumor size, invasion of anterior pancreatic capsule, and lymph node metastasis were also variables significantly correlating to pain intensity. Survival also correlated with pain intensity: the median survival periods were 29 months in patients without pain, 19 months in those with mild pain, and 9 months in those with severe pain who required analgesics. Larger pancreatic tumors, invasion of the intrapancreatic nerves, and invasion of the anterior pancreatic capsule may cause abdominal and/or back pain in patients with resectable pancreatic cancer. This study also suggests clinical implications of the pain intensity as a prognostic factor in patients with resectable pancreatic cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11291930     DOI: 10.1097/00006676-200104000-00009

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  9 in total

Review 1.  Indications for staging laparoscopy in pancreatic cancer.

Authors:  Antonella De Rosa; Iain C Cameron; Dhanwant Gomez
Journal:  HPB (Oxford)       Date:  2015-11-18       Impact factor: 3.647

2.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

3.  Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma.

Authors:  Rosalie A Carr; Alexandra M Roch; Xin Zhong; Eugene P Ceppa; Nicholas J Zyromski; Attila Nakeeb; C Max Schmidt; Michael G House
Journal:  J Gastrointest Surg       Date:  2017-08-07       Impact factor: 3.452

4.  The neurotrophic factor artemin promotes pancreatic cancer invasion.

Authors:  Güralp O Ceyhan; Nathalia A Giese; Mert Erkan; Annika G Kerscher; Moritz N Wente; Thomas Giese; Markus W Büchler; Helmut Friess
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Pancreatic cancer--low survival rates.

Authors:  Hans G Beger; Bettina Rau; Frank Gansauge; Gerd Leder; Michael Schwarz; Bertram Poch
Journal:  Dtsch Arztebl Int       Date:  2008-04-04       Impact factor: 5.594

6.  Pain sensation in pancreatic diseases is not uniform: the different facets of pancreatic pain.

Authors:  Jan G D'Haese; Mark Hartel; Ihsan Ekin Demir; Ulf Hinz; Frank Bergmann; Markus W Büchler; Helmut Friess; Güralp O Ceyhan
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 7.  Pain management for hepatobiliary cancer.

Authors:  Daniel Halpert; Michael A Erdek
Journal:  Curr Treat Options Oncol       Date:  2008-08-19

8.  Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia.

Authors:  Junhui Li; Qingyong Ma; Han Liu; Kun Guo; Feng Li; Wei Li; Liang Han; Fengfei Wang; Erxi Wu
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

9.  Quantitative definitions of pain, CA19-9, and tumor size as high-risk features of resectable pancreatic cancer: a single-center retrospective cohort study.

Authors:  Dongni Xu; Jiangling Wang; Ting Liu; Zhuoshan Huang; Jianwei Luo; Yuqing Chen; Yanan Lu
Journal:  Gland Surg       Date:  2021-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.